BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37425686)

  • 1. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis.
    Gobbo F; Zingariello M; Verachi P; Falchi M; Arciprete F; Martelli F; Peli A; Mazzarini M; Vierstra J; Mead-Harvey C; Dueck AC; Sarli G; Nava S; Sgalla G; Richeldi L; Migliaccio AR
    bioRxiv; 2023 Sep; ():. PubMed ID: 37425686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1
    Verachi P; Gobbo F; Martelli F; Falchi M; di Virgilio A; Sarli G; Wilke C; Bruederle A; Prahallad A; Arciprete F; Zingariello M; Migliaccio AR
    Exp Hematol; 2023 Jan; 117():43-61. PubMed ID: 36191885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel interaction between megakaryocytes and activated fibrocytes increases TGF-β bioavailability in the Gata1(low) mouse model of myelofibrosis.
    Zingariello M; Ruggeri A; Martelli F; Marra M; Sancillo L; Ceglia I; Rana RA; Migliaccio AR
    Am J Blood Res; 2015; 5(2):34-61. PubMed ID: 27069753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the
    Verachi P; Gobbo F; Martelli F; Martinelli A; Sarli G; Dunbar A; Levine RL; Hoffman R; Massucci MT; Brandolini L; Giorgio C; Allegretti M; Migliaccio AR
    Front Oncol; 2022; 12():853484. PubMed ID: 35392239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets to cure primary myelofibrosis from studies on Gata1
    Zingariello M; Martelli F; Verachi P; Bardelli C; Gobbo F; Mazzarini M; Migliaccio AR
    IUBMB Life; 2020 Jan; 72(1):131-141. PubMed ID: 31749302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.
    Zetterberg E; Verrucci M; Martelli F; Zingariello M; Sancillo L; D'Amore E; Rana RA; Migliaccio AR
    Platelets; 2014; 25(7):539-47. PubMed ID: 24176039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in
    Zingariello M; Verachi P; Gobbo F; Martelli F; Falchi M; Mazzarini M; Valeri M; Sarli G; Marinaccio C; Melo-Cardenas J; Crispino JD; Migliaccio AR
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1
    Arciprete F; Verachi P; Martelli F; Valeri M; Balliu M; Guglielmelli P; Vannucchi AM; Migliaccio AR; Zingariello M
    Exp Hematol; 2023 May; 121():30-37. PubMed ID: 36863479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
    Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
    J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.
    Reilkoff RA; Peng H; Murray LA; Peng X; Russell T; Montgomery R; Feghali-Bostwick C; Shaw A; Homer RJ; Gulati M; Mathur A; Elias JA; Herzog EL
    Am J Respir Crit Care Med; 2013 Jan; 187(2):180-8. PubMed ID: 23220917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
    Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.
    Shimbori C; Upagupta C; Bellaye PS; Ayaub EA; Sato S; Yanagihara T; Zhou Q; Ognjanovic A; Ask K; Gauldie J; Forsythe P; Kolb MRJ
    Thorax; 2019 May; 74(5):455-465. PubMed ID: 30808717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
    Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
    bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
    Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
    Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary Fibrosis.
    Bellaye PS; Shimbori C; Upagupta C; Sato S; Shi W; Gauldie J; Ask K; Kolb M
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):461-470. PubMed ID: 29115860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.
    Zingariello M; Martelli F; Ciaffoni F; Masiello F; Ghinassi B; D'Amore E; Massa M; Barosi G; Sancillo L; Li X; Goldberg JD; Rana RA; Migliaccio AR
    Blood; 2013 Apr; 121(17):3345-63. PubMed ID: 23462118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.